Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erhard Seifried

Showing results (131-140 of 189) with videos related to

Pageof 19
Sort By:
Vox Sanguinis|July 8, 2020
Introduction of principles of blood management to healthy donor bone marrow harvestingSoo-Zin Kim-Wanner, Beate Luxembourg, Alexander H Schmidt, et al.
Transfusion|May 1, 2018
Granulocyte antibodies in male blood donors: can they trigger transfusion-related acute lung injury?Xuan-Duc Nguyen, Torsten J Schulze, Peter Bugert, et al.
Oncogenesis|May 18, 2021
PRMT6 activates cyclin D1 expression in conjunction with the transcription factor LEF1Lucas Schneider, Stefanie Herkt, Lei Wang, et al.
Transfusion|August 29, 2006
A comparison of three rapid bacterial detection methods under simulated real-life conditionsMichael Schmidt, Michael K Hourfar, Sven-Boris Nicol, et al.
Transfusion|August 24, 2007
Blood donor screening for parvovirus B19 in Germany and AustriaMichael Schmidt, Anna Themann, Camilla Drexler, et al.
Journal of Translational Medicine|August 13, 2017
Erythrocyte depletion from bone marrow: performance evaluation after 50 clinical-scale depletions with Spectra Optia BMCSoo-Zin Kim-Wanner, Gesine Bug, Juliane Steinmann, et al.
Thrombosis and Haemostasis|June 4, 2009
VKORC1 deficiency in mice causes early postnatal lethality due to severe bleedingGabriele Spohn, Andre Kleinridders, F Thomas Wunderlich, et al.
Vox Sanguinis|April 29, 2020
Reducing the red blood cell transfusion threshold from 8·0 g/dl to 7·0 g/dl in acute myeloid leukaemia patients undergoing induction chemotherapy reduces transfusion rates without adversely affecting patient outcomeOlivier Ballo, Philine Fleckenstein, Fagr Eladly, et al.
Vox Sanguinis|November 12, 2019
The systematic use of evidence-based methodologies and technologies enhances shared decision-making in the 2018 International Consensus Conference on Patient Blood ManagementHans Van Remoortel, Kari Aranko, Markus M Mueller, et al.
BMC Medicine|September 19, 2023
Small volume bone marrow aspirates with high progenitor cell concentrations maximize cell therapy dose manufacture and substantially reduce donor hemoglobin lossJeremy Epah, Gabriele Spohn, Kathrin Preiß, et al.
Pageof 19

Showing results (131-140 of 189) with videos related to

Sort By:
Pageof 19
Vox Sanguinis|July 8, 2020
Introduction of principles of blood management to healthy donor bone marrow harvestingSoo-Zin Kim-Wanner, Beate Luxembourg, Alexander H Schmidt, et al.
Transfusion|May 1, 2018
Granulocyte antibodies in male blood donors: can they trigger transfusion-related acute lung injury?Xuan-Duc Nguyen, Torsten J Schulze, Peter Bugert, et al.
Oncogenesis|May 18, 2021
PRMT6 activates cyclin D1 expression in conjunction with the transcription factor LEF1Lucas Schneider, Stefanie Herkt, Lei Wang, et al.
Transfusion|August 29, 2006
A comparison of three rapid bacterial detection methods under simulated real-life conditionsMichael Schmidt, Michael K Hourfar, Sven-Boris Nicol, et al.
Transfusion|August 24, 2007
Blood donor screening for parvovirus B19 in Germany and AustriaMichael Schmidt, Anna Themann, Camilla Drexler, et al.
Journal of Translational Medicine|August 13, 2017
Erythrocyte depletion from bone marrow: performance evaluation after 50 clinical-scale depletions with Spectra Optia BMCSoo-Zin Kim-Wanner, Gesine Bug, Juliane Steinmann, et al.
Thrombosis and Haemostasis|June 4, 2009
VKORC1 deficiency in mice causes early postnatal lethality due to severe bleedingGabriele Spohn, Andre Kleinridders, F Thomas Wunderlich, et al.
Vox Sanguinis|April 29, 2020
Reducing the red blood cell transfusion threshold from 8·0 g/dl to 7·0 g/dl in acute myeloid leukaemia patients undergoing induction chemotherapy reduces transfusion rates without adversely affecting patient outcomeOlivier Ballo, Philine Fleckenstein, Fagr Eladly, et al.
Vox Sanguinis|November 12, 2019
The systematic use of evidence-based methodologies and technologies enhances shared decision-making in the 2018 International Consensus Conference on Patient Blood ManagementHans Van Remoortel, Kari Aranko, Markus M Mueller, et al.
BMC Medicine|September 19, 2023
Small volume bone marrow aspirates with high progenitor cell concentrations maximize cell therapy dose manufacture and substantially reduce donor hemoglobin lossJeremy Epah, Gabriele Spohn, Kathrin Preiß, et al.
Pageof 19